Experts say early results from Avandia study not reassuring, despite Glaxo's claim

From the Canadian Press:
The maker of the controversial diabetes pill Avandia on Tuesday published preliminary results of a study that the company claims show the drug does not raise heart risks. However, experts say the results are inconclusive and even seem to suggest more risk from the drug.

More people on Avandia suffered heart problems than those on other diabetes drugs - a bad sign even if the difference was so small that it could have occurred by chance alone, some doctors said. ...more